Lilly and EVA Pharma Secure Approval to Distribute Locally Manufactured Insulin in Egypt
Under this agreement, Lilly has been supplying its active pharmaceutical ingredient (API) for insulin to EVA Pharma at a significantly reduced price and providing pro-bono technology transfer to enable EVA Pharma to formulate, fill and finish insulin vials and cartridges.
EVA Pharma | 18/12/2024 | By Aishwarya
Lilly Signs Deal with EVA Pharma to Expand Access to baricitinib
This collaboration is part of the Lilly 30x30 initiative, which aims to improve access to quality health care for 30 million people living in resource-limited settings annually by 2030.
EVA Pharma | 05/09/2024 | By Aishwarya | 155
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy